Pfizer Beats Estimates, Lowers Covid Revenue Guidance to $4 Billion
Macro·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Pfizer reported stronger-than-expected quarterly profits, driven by robust demand for its blood thinner, Eliquis.
The company has adjusted its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Pfizer
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.”
CNBC — Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs“Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis”
Yahoo Finance — Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis